
    
      Group A:Adriamycin (60 mg/m2, d1, qd22) 75 mg/m2 may be applied instead of 60 mg/m2 for
      patients between 60 and 70 years of age (optional) Group B:Trofosfamide (300 mg absolute p.o.
      qd over 7 days, then 150 mg p.o. absolute qd continuously) In case of absence of any toxicity
      during treatment with trofosfamide 150 mg absolute a dose escalation to 200 mg absolute is
      allowed (optional)
    
  